SUPERIORITY OF AVCF (ADRIAMYCIN, VINCRISTINE, CYCLOPHOSPHAMIDE, AND 5-FLUOROURACIL) OVER CMF (CYCLOPHOSPHAMIDE, METHOTREXATE, AND 5-FLUOROURACIL) AS ADJUVANT CHEMOTHERAPY FOR BREAST CANCER: A PHASE III TRIAL OF ASSOCIATION ONCOFRANCE | Publicación